KDR/Flk-1 tyrosine kinase, one of the two receptors for Vascular Endothelial Growth Factor (VEGF) has been shown to generate the major part of mitotic signals in endothelial cells, although the mechanisms are poorly understood. Here we examined the processing and signal transduction of KDR/Flk-1. Both in endothelial cells and in NIH3T3 cells expressing KDR/Flk-1, an immature form of KDR/Flk-1 with a molecular mass of about 150 kDa was glycosylated to create a 200 kDa intermediate, and after further glycosylation a mature 230 kDa was expressed on the cell surface. Only this 230 kDa form was rapidly and transiently phosphorylated on tyrosine residues in the presence of VEGF. As a major substrate of KDR/Flk-1, PLC-g was found to be rapidly tyrosine-phosphorylated and associated with KDR/Flk-1 both in endothelial cells and NIH3T3 cells. Interestingly, however, a prompt activation of MAP kinase and subsequent strong mitotic signaling were generated only in the endothelial cell background. Activation of MAP kinase in NIH3T3 cells overexpressing KDR/Flk-1 showed a slower response as maximum levels were only attained after 20 min compared to 5 min in sinusoidal endothelial cells. These results suggest that the KDR/Flk-1 utilizes cell typespeci®c signal transduction pathway(s) for MAP kinase activation and the mitotic response in endothelial cells.
Introduction
Angiogenesis is known to be an essential process not only under physiological conditions but also under pathological conditions such as diabetic retinopathy and tumor vascularization (Risau et al., 1988; Micaelson, 1948; Folkman, 1990) . Recent studies have revealed that Vascular Endothelial Growth Factor (VEGF), also referred to as Vascular Permeability Factor (VPF), is an important element for many angiogenic processes under normal and abnormal states Shibuya, 1995; Mustonen and Alitro, 1995) . VEGF carries two major biological activities, one is the capacity to stimulate vascular endothelial cell proliferation (Ferrara and Henzel, 1989; Leung et al., 1989; Connolly et al., 1989) and the other is the ability to increase microvessel permeability to macromolecules (Senger et al., 1983; Keck et al., 1989) . In addition, some additional biological activities have recently been reported: VEGF was found to stimulate macrophage migration (Clauss et al., 1993; Barleon et al., 1996) , protease production in endothelial cells (Pepper et al., 1991; Unemori et al., 1992) and the resistance of hematopoietic cells to radiation-induced apoptosis (Katoh et al., 1995) . The mechanism underlying these diverse processes will require further characterization.
VEGF binds two tyrosine kinase receptors, Flt-1 and KDR/Flk-1 with high anity (De Vries et al., 1992; Millauer et al., 1993) . Flt-1 and KDR/Flk-1 have common structural characteristics and share 7-Immunoglobulin (Ig)-like domains in the extracellular domain and a long kinase insert in the middle of the kinase domain (Shibuya et al., 1990; Matthews et al., 1991; Terman et al., 1992) . Since the mRNAs on the Flt-1 and KDR/Flk-1 are speci®cally expressed in the vascular endothelial cells (Jakeman et al., 1993; Eichmann et al., 1993; Kaipainen et al., 1993; Quinn et al., 1993; Yamane et al., 1994) , VEGF has been considered to be in most cases only relevant to the vascular system. However, it is an obviously important and interesting question to know whether VEGF and its receptors utilize endothelial cell-speci®c signal transduction pathway(s) for mitosis and differentiation. Although the 7-Ig-type Flt family members (Flt-1, KDR/Flk-1 and Flt-4) are structurally related to the 5-Ig-type receptors such as PDGF-R, CSF-1-R (Fms) and SCF-R (Kit), the Flt family receptors do not have tyrosine residues of recognition motif for phosphatidylinositol 3 kinase (PI 3 kinase; tyrosine-X-X-methionine) within the kinase insert. These tyrosine residues are conserved among the 5-Ig receptors and are autophosphorylated to transduce mitotic signals as an essential manner (Aprelikova et al., 1992; Galland et al., 1993; Fanti et al., 1992; Valius and Kazlauskas, 1993) . Thus, these structural dierences at critical residues between 7-Ig-and 5-Ig-type receptors suggest that the VEGF receptors utilize a signaling machinery in endothelial cells dierent from those used by the 5-Ig-type receptors in ®broblasts and hematopoietic cells.
Further, it is an open question whether the Flt-1 and KDR/Flk-1 tyrosine kinases phosphorylate and activate similar or very dierent substrates within the cell. Recent studies on the targeting of these two VEGF receptor genes demonstrated that KDR/¯k-1-minus homozygous mice are lethal at 8.5 to 9.5 embryonic days due to the lack of endothelial cell growth and blood vessel formation, as well as an extremely poor hematopoiesis (Shalaby et al., 1995) . On the other hand,¯t-1-minus homozygous mice are also lethal at the same stage but this is rather due to overgrowth of endothelial cells and disorganization of blood vessels (Fong et al., 1995) . Based on these data, at least at the early stage of embryogenesis, KDR/Flk-1 appears to function in the proliferation of endothelial cells and Flt-1 seems to be required more for dierentiation and vascular organization. However, the biochemical processes that underlie these signaling pathways remain largely unknown.
As an initial attempt to solve these problems, we showed recently that the Flt-1 tyrosine kinase is unique in the sense that it possesses a very weak autophosphorylation activity and almost undetectable mitogenic activity in response to VEGF when overexpressed in porcine aortic endothelial cells (Waltenberger et al., 1994) or NIH3T3 ®broblast cells (Seetharam et al., 1995) . Furthermore, MAP kinase was only very weakly activated in the Flt-1-expressing NIH3T3 cells, although phospholipase C-g (PLC-g) and GTPase activating protein (GAP) complex were tyrosine phosphorylated to some extent in NIH3T3 cell background (Seetharam et al., 1995) .
More recently Flt-1 kinase has been shown to associate with p85 subunit of PI 3 kinase when these molecules were overexpressed in yeasts (Conningham et al., 1995) . It is not clear yet whether or not this interaction could be seen in primary endothelial cells. In addition, PLC-g, Nck, PI 3 kinase and GAP have been reported to be tyrosine phosphorylated in endothelial cells in the presence of VEGF (Guo et al., 1995) . However, it remains to be elucidated which VEGF receptor (Flt-1 or KDR/Flk-1) is involved in the phosphorylation and activation of each substrate.
To understand more precisely the signal transduction mechanism of VEGF receptors, in this study we have expressed human KDR/Flk-1 receptor on NIH3T3 cells and examined the processing as well as the signal transduction pathway to the nucleus. Our results strongly suggest that the transduction of signals from KDR/Flk-1 to MAP kinase in endothelial cells is dierent from that in NIH3T3 ®broblasts.
Results
VEGF binds KDR/Flk-1 as well as Flt-1 in primary endothelial cells
The mRNAs of VEGF receptors (Flt-1 and KDR/ Flk-1) have been reported to be strongly expressed in sinusoidal endothelial cells (Yamane et al., 1994) . However, their expression at the level of proteins has not been studied extensively in these cells. Therefore, we ®rst examined the expression of active VEGF receptors (Flt-1 and KDR/Flk-1) in the primary cultures of rat sinusoidal endothelial cells. As shown in Figure 1a , 125 I-VEGF bound to the speci®c receptors present on sinusoidal endothelial cells, but not on 3Y1 rat ®broblasts which were used as a negative control. The binding of 125 I-VEGF was competitively inhibited by adding excess unlabeled VEGF.
Cross-linking experiments also indicated the existence of a complex between 125 I-VEGF and receptors on sinusoidal endothelial cells (Figure 1b ). These complexes were speci®cally immunoprecipitated by either anti-Flt-1 or anti-KDR/Flk-1 antiserum. I-VEGF was cross-linked to the receptors using DSS. The 3Y1 cells or sinusoidal endothelial cells were lysed in RIPA buer and directly analysed using SDS ± PAGE (lane 1 or 2, respectively). Sinusoidal endothelial cell lysates were immunoprecipitated with preimmune serum (lane 3), anti-Flt-1 (lanes 4 and 5) or KDR/Flk-1 antiserum (lanes 6 and 7). In lanes 5 and 7, the corresponding excess antigen was added as a competitor. TCL : total cell lysate, IP: immunoprecipitation The immunoprecipitations of these receptors were blocked by the pretreatment of the antisera with the immunizing antigens. No bands were observed in immunoprecipitates using pre-immune serum. The apparent mass of the 125 I-VEGF-KDR/Flk-1 complex was about 280 kDa and bigger by about 50 kDa compared with 125 I-VEGF-Flt-1 complex. This mass dierence may be due to post-translational modifications such as glycosylation of KDR/Flk-1 and Flt-1 proteins, since the calculated molecular weights as deduced from the amino acid sequence (147 kDa and 145 kDa) are almost the same.
Biochemical processing of KDR/Flk-1 protein within the cells
In order to investigate the biological features of KDR/ Flk-1 in a simple model system, we transfected a plasmid containing cDNA encoding the full length of human KDR/Flk-1 into NIH3T3 cells (Sawano et al., 1996) . Stable transfectants overexpressing KDR/Flk-1 were obtained and designated as NIH3T3-KDR cells. The expressed KDR/Flk-1 was detected as two bands with apparent masses of 230 kDa and 200 kDa by Western blotting with a polyclonal rabbit immune serum against the C-terminal region of KDR/Flk-1 (Figure 2a ). These bands were not present in NIH3T3 cells transfected with vector alone (Figure 4a ).
The extracellular domain of KDR/Flk-1 contains 18 potential N-linked glycosylation sites (Terman et al., 1992) . To determine whether the KDR/Flk-1 was modi®ed by N-linked glycosylation, NIH3T3-KDR cells were treated with various concentrations of tunicamycin, which blocks N-linked glycosylation. When treated with tunicamycin, the two bands of KDR/Flk-1 now migrated as a single band with an apparent molecular mass of 180 kDa (Figure 2a ). Similar results were obtained when sinusoidal endothelial cells were treated with tunicamycin, but the size of KDR/Flk-1 proteins in sinusoidal endothelial cells and ®broblasts was slightly dierent; in sinusoidal endothelial cells, the upper band was about 240 kDa and the lower band was 190 kDa. Since the tunicamycintreated forms of KDR/Flk-1s in both cells were in almost the same size range of 180 kDa, these results suggest that the mass dierences between KDR/Flk-1s detected in sinusoidal endothelial cells and those in NIH3T3-KDR cells are due to a minor dierence in the level of N-linked carbohydrate content.
In order to ascertain whether or not the two forms of KDR/Flk-1 (230 kDa and 200 kDa) expressed in NIH3T3 cells are the mature and functional forms of this receptor, NIH3T3-KDR cells were surface-labeled with sulpho-NHS-Biotin. This compound is not permeable to the plasma membrane, and thus, the biotinylation is restricted to the molecules on the cell surface. Biotinylated proteins were immunoprecipitated with anti-KDR/Flk-1 antiserum. Figure 2b shows that only 230 kDa form was labeled with biotin, whereas 200 kDa form was not. This indicates that the 230 kDa form is the major KDR/Flk-1 present on the cell surface.
Pulse-chase experiments were also used to analyse the metabolism of KDR/Flk-1 protein in NIH3T3-KDR cells (Figure 2c ). After labeling with Thus we concluded that the upper 230 kDa form of KDR/Flk-1 represents a fully glycosylated protein expressed at the cell surface, and the 200 kDa form is the immature KDR/Flk-1 protein localized within NIH3T3-KDR cells.
VEGF stimulated only a weak proliferation of NIH3T3-KDR cells
Since VEGF induced a signi®cant mitogenic response in sinusoidal endothelial cells in a strictly VEGFdependent manner (Yamane et al., 1994) , we investigated the possibility that VEGF could also stimulate proliferation of NIH3T3-KDR cells. These cells express about 10 4 molecules of KDR/Flk-1 per cell, which is similar to the level found on sinusoidal endothelial cells (Sawano et al., 1996) . NIH3T3-KDR cells were starved overnight in DMEM without serum and supplemented with transferrin and insulin. When stimulated with VEGF, NIH3T3-KDR cells showed only a weak tendency to proliferate as shown in Figure  3 . On the other hand, stimulation with 10% CS lead to a rapid cell growth, which was seven to eightfold higher than that stimulated with VEGF. BSA alone could hardly maintain the viability of cells and did not stimulate the mitogenic activity. NIH3T3 cells transfected with vector alone showed no response to VEGF (data not shown).
In addition, [ 
Phosphorylation of KDR/Flk-1 in response to VEGF
We attempted to elucidate the molecular basis for the dierence in KDR/Flk-1-mediated signaling between sinusoidal endothelial cells and NIH3T3 ®broblasts. We examined the autophosphorylation level of KDR/ Flk-1, which is considered the ®rst step of the signaling cascade. Immunoblotting of the KDR/Flk-1 immunoprecipitates with antiphosphotyrosine antibody revealed that the 230 kDa protein, which is the mature form of KDR/Flk-1 expressed on the cell surface, was the major tyrosine-phosphorylated protein. The more rapidly migrating form of KDR/Flk-1 i.e. 200 kDa protein, that is not present on the cell surface, was not phosphorylated in response to VEGF (Figure 4a, upper panel) . In sinusoidal endothelial cells, the 240 kDa KDR/Flk-1 was also tyrosine-phosphorylated after VEGF stimulation (Figure 4a , lower panel) and showed similar kinetics ( Figure 4b ). Therefore, we consider that the autophosphorylation of KDR/Flk-1 is essentially normal in NIH3T3-KDR cells with respect to both the level and the time course of phosphorylation.
To further characterize the KDR/Flk-1 signaling pathway activated by VEGF, we analysed the tyrosinephosphorylation of cellular proteins in total cell lysates of VEGF-stimulated NIH3T3-KDR cells (Figure 4b ). The 230 kDa KDR/Flk-1 was found to be rapidly and transiently phosphorylated, reaching a maximum Since the 150 kDa protein except for 230 kDa KDR/ Flk-1 was the most clear band phosphorylated on tyrosine residues in response to VEGF and showed similar phosphorylation kinetics to KDR/Flk-1, it appears to be the direct and major substrate of the activated KDR/Flk-1 in NIH3T3 cells. Because of the similarity of the molecular weights, we examined the possibility that the 150 kDa band might be, at least partially, made up of PLC-g known to be involved in tyrosine kinase signaling cascades (Rhee et al., 1989; Schlessinger and Ullrich, 1992) . To investigate the levels of phosphorylation of PLC-g, the cell lysates from VEGF-stimulated NIH3T3-KDR cells were immunoprecipitated with anti-PLC-g antibodies, separated by SDS ± PAGE, transferred to Immobilon, and the blots were probed with anti-phosphotyrosine antibody. The results (Figure 5a ) showed that PLC-g was strongly phosphorylated on tyrosine residues in response to VEGF.
Moreover, the levels of tyrosine-phosphorylation of the 150 kDa protein were greatly reduced in the lysates which had ®rst been immunoabsorbed with anti-PLC-g antibodies, indicating that most of the 150 kDa band is PLC-g (Figure 5b ).
In order to determine if PLC-g was associated with KDR/Flk-1, aliquots of cell lysates were immunoprecipitated with either anti-KDR/Flk-1 or anti-PLC-g antibodies and immunoblotted with the reciprocal antibody. As shown in Figure 5c , the PLC-g was found to be associated with KDR/Flk-1 upon VEGF stimulation. Thus we conclude that one of the major substrates of KDR/Flk-1 tyrosine kinase in NIH3T3 cells is the PLC-g molecule.
A dierence in the kinetics of VEGF-induced MAP kinase activation between sinusoidal endothelial cells and NIH3T3-KDR cells MAP kinase is known to be activated by a wide variety of extracellular signals including growth factors, and functions in the MAP kinase cascade that plays a critical role in the regulation of cell growth and dierentiation (Gotoh et al., 1990 ). Thus we examined MAP kinase activity in NIH3T3-KDR cells using the in gel kinase assay ( Figure 6 ).
In sinusoidal endothelial cells, maximum activation of MAP kinase was found to occur between 3 and 5 min after VEGF stimulation. The level of the activated kinase then declined to nearly basal levels after 10 min. Essentially the same kinetics were observed in 10% CS-stimulated NIH3T3-KDR cells.
Stimulation of NIH3T3-KDR cells with VEGF also increased the MAP kinase activity, but interestingly the kinetics of the activation were remarkably slower, as maximum activation was attained only after about 20 min and declined gradually to nearly basal levels at 60 min. Neo-resistant NIH3T3 cells carrying vector alone did not show any changes in MAP kinase activity after VEGF stimulation.
Downregulation of PKC abolished VEGF-induced MAP kinase activation in NIH3T3-KDR cells
Slow kinetics in the activation of MAP kinase was previously reported in the case of 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated PC12 cells (Gotoh et al., 1990) . Since PLC-g as well as TPA is known to activate protein kinase C (PKC) (Nishizuka, 1988) , we examined the possibility that VEGF-induced MAP kinase activation in NIH3T3-KDR cells might be due to stimulation of PKC. The response of PC12 cells to TPA was shown to be abolished by prolonged treatment of the cells with TPA for 24 h because of the downregulation of PKC (Nishizuka, 1988) . As shown in Figure 7 , when NIH3T3-KDR cells were pretreated with TPA for 24 h, VEGF-induced MAP kinase activation was severely impaired, whereas 10% CS-induced one was almost intact, indicating that the impairment in VEGF-induced MAP kinase activity was not due to the loss of MAP kinase activity. In contrast, pretreatment of these cells with dimethyl sulfoxide (DMSO) alone, a solvent for TPA, had no eect on VEGF-induced MAP kinase activation. Moreover, the levels of VEGF-induced tyrosinephosphorylation on both KDR/Flk-1 and PLC-g in NIH3T3-KDR cells pretreated with TPA were almost the same as those in NIH3T3-KDR cells pretreated with DMSO alone (data not shown). Therefore, we conclude that the slow activation of MAP kinase in Figure 3 Growth curve of NIH3T3-KDR cells in response to VEGF. NIH3T3-KDR cells were plated in serum-free medium supplemented with transferrin and insulin. Next day, cells were incubated with 50 ng/ml of VEGF, 50 ng/ml of BSA or 10% CS. The cells were cultured and the numbers of viable cells were counted every 24 h as indicated. These experiments were performed twice with essentially the same results. Cell numbers were the average of duplicate samples NIH3T3-KDR cells after stimulation with VEGF is mainly mediated through the activation of PKC. The rapid activation of MAP kinase and the strong mitotic signals found in primary endothelial cells suggest the existence of an endothelial cell-speci®c signal transduction pathway linking VEGF receptors, KDR/Flk-1 or Flt-1, to the nucleus.
Discussion
The processing of KDR/Flk-1
In this study we have shown the processing of the VEGF receptor KDR/Flk-1 and the signal transduction in KDR/Flk-1-expressing NIH3T3 cells as well as in endothelial cells. KDR/Flk-1 was initially synthesized as a 150 kDa protein and rapidly glycosylated to a 200 kDa intermediate form, and then further glycosylated at a slower rate to a mature 230 kDa protein which is expressed on the cell surface. The overall processing steps, i.e. a rapid glycosylation of a nascent receptor protein to an intermediate, and a slower glycosylation to the mature form are essentially the same for Flt-1, although the sizes of these mature receptors are signi®cantly dierent (KDR/Flk-1, 230 kDa; Flt-1, 180 kDa) (Figure 8) .
The processing of CSF-1-R which belongs to the 5-Ig receptor and distantly related to the 7-Ig type Flt family was previously shown to be similar to those of KDR/Flk-1 described here (Rettenmier et al., 1987; Rohrschneider et al., 1989) . This indicates that 5-Ig/7- Ig receptor tyrosine kinase supergene family utilizes a similar processing machinery. The biological significance of glycosylation of VEGF receptors is not clear, but we have recently shown that heparin or heparinlike molecules can modulate the binding of VEGF to these receptors (Cohen et al., 1995) . Thus, the correct modi®cation of the nascent receptors appears to be important for the precise interaction with, and regulation of these receptors by VEGF.
Autophosphorylation of KDR/Flk-1
In sinusoidal endothelial cells, 240 kDa protein(s) was rapidly tyrosine-phosphorylated upon stimulation with VEGF. Although 240 kDa band(s) might include a protein(s) other than KDR/Flk-1, the relative levels of tyrosine-phosphorylated 240 kDa protein(s) to KDR/ Flk-1 in total cell lysates were almost the same as those in the immunoprecipitates prepared with anti-KDR/ Flk-1 antiserum (Figure 4a, lower panel) . This suggests that the major portion of the tyrosine-phosphorylated 240 kDa band in primary endothelial cells is KDR/ Flk-1 itself. Autophosphorylation of KDR/Flk-1 occurred rapidly and transiently in the NIH3T3 cell background. The time course was almost the same as that of endogenously expressed KDR/Flk-1 in the primary endothelial cells, suggesting that the activation of the KDR/Flk-1 tyrosine kinase through dimerization on binding VEGF is essentially the same in both endothelial and ®broblast cells.
We have recently shown that another VEGF receptor Flt-1 is rather weakly autophosphorylated in both primary endothelial cells and NIH3T3-Flt-1 cells (Waltenberger et al., 1994; Seetharam et al., 1995) . The biological meaning of these signi®cant dierences between the structurally related receptors KDR/Flk-1 and Flt-1 is not clear at this time. Transphosphorylation on tyrosine residues between KDR/Flk-1 and Flt-1 seems relatively low, if any, because in the primary endothelial cells which express both receptors at high levels the phosphorylation level of Flt-1 still remains very low (data not shown).
The higher levels of autophosphorylation in KDR/ Flk-1 compared to that of Flt-1 appears not to be due to a dierence of phosphatases speci®c to each receptor, since the in vitro protein kinase assay after immunoprecipitation with antiserum speci®c to KDR/ Flk-1 or Flt-1 showed a strong dierence in the kinase activity in response to VEGF similar to the cases in vivo (Sawano, Takahashi and Shibuya, unpublished data) . The tyrosine phosphorylation sites of the KDR/ Flk-1 were reported by using a KDR/Flk-1 tyrosine kinase region expressed in E. coli (Dougher-Vermazen et al., 1994) . It remains to be seen whether or not these tyrosine residues are similarly autophosphorylated in vivo in mammalian endothelial cells.
PLC-g is one of the major substrates for KDR/Flk-1
In this study we have found that the major substrate for KDR/Flk-1 in NIH3T3 cells is PLC-g. PLC-g was rapidly and transiently phosphorylated on tyrosine residues with similar kinetics to that of KDR/Flk-1 autophosphorylation in endothelial cells, and associated with KDR/Flk-1. These results strongly suggest that KDR/Flk-1 directly phosphorylates PLC-g on tyrosine residues. In a recent study, we have shown that tyrosine phosphorylation of PLC-g takes place at a signi®cantly higher level in endothelial cells (Guo et al., 1995) but at a much lower level in Flt-1 overexpressing NIH3T3 cells (Seetharam et al., 1995) . Therefore, we consider that the endogenous KDR/Flk-1 is the major protein kinase for PLC-g in endothelial cells after stimulation with VEGF.
After stimulation with VEGF, tyrosine-phosphorylated proteins were found to be rare, or weakly phosphorylated in NIH3T3-KDR cells with the exception of PLC-g and KDR/Flk-1. On the other hand, a set of proteins was observed to be phosphorylated on tyrosine residues in rat sinusoidal endothelial cells in response to VEGF (Yamane et al., 1994) . These results suggest that the endothelial cells contain several cellular proteins which are eciently phosphorylated by KDR/Flk-1 or Flt-1. We also studied several known signal transduction molecules that are involved in the signaling of tyrosine PLC-g binds to the region containing phosphotyrosines, and is tyrosine-phosphorylated and activated. PLC-g may catalyze PIP 2 into IP 3 and DAG, which in turn may activate PKC. Activated PKC stimulates the activation of MAP kinase in slow kinetics as shown in Figure 6 kinase receptors. PI 3 kinase has been shown to bind to the consensus sequence tyrosine-X-X-methionine motif, which KDR/Flk-1 does not contain within the kinase insert domain, and to mediate the signals in many other tyrosine kinases such as PDGF receptors. In either NIH3T3-KDR cells or sinusoidal endothelial cells, PI 3 kinase does not appear to mediate the signals originating from activated KDR/Flk-1 or Flt-1, since no phosphorylation of the regulatory subunit (p85) of PI 3 kinase was found in response to VEGF. Moreover, Wortmannin, a potent inhibitor of PI 3 kinase, had no eects on VEGF-induced MAP kinase activation in either cells although it severely inhibited PDGFinduced one. Activation of Src family members such as Src, Fyn, Lyn and Yes was not found either in NIH3T3-KDR cells or in sinusoidal endothelial cells using in vitro kinase assay. Shc is one of the important adaptor proteins, but there was no signi®cant increase of phosphorylation levels in response to VEGF in either cells. Therefore, PI 3 kinase, Shc or some Src family members appear not to be the major signal transducers in primary endothelial cells. Slight discrepancy upon phosphorylation of PI 3 kinase between our data and the observation reported by Guo et al. (1995) might be due to the dierence of endothelial cells used in the experiments.
Possibility of endothelial cell-speci®c signal transduction pathway(s)
Although KDR/Flk-1 and its substrate PLC-g were highly phosphorylated in NIH3T3-KDR cells, stimulation of cell proliferation in NIH3T3 ®broblasts was weak compared with the growth response of primary endothelial cells to VEGF or that of NIH3T3-KDR to serum. There exist at least two possibilities to explain this lower level of mitotic signaling in NIH3T3 cells: one is that the cooperation of KDR/Flk-1 and Flt-1 receptors is essential to generate a strong mitotic signal, since these receptors are expressed in primary endothelial cells at high levels. Another possibility is that a VEGF receptor such as KDR/Flk-1 can utilize an endothelial cell speci®c signal transduction pathway(s) that may be absent or insucient in NIH3T3 cells or other types of cells. The former possibility seems unlikely because¯t-1(7/7) mouse embryos showed overgrowth of endothelial cells in the developing vascular systems (Fong et al., 1995) .
In addition, we examined proliferation of NIH3T3 cells coexpressing Flt-1 and KDR/Flk-1 in the presence of VEGF. However, the growth rate was almost the same as that of NIH3T3-KDR shown in Figure 3 , about eight to tenfold lower than the proliferation upon stimulation with serum (Takahashi, Yamaguchi and Shibuya, unpublished) . These data also support the possibility that coexpression of two VEGF receptors is not the main reason for rapid growth of endothelial cells in the presence of VEGF. Thus, we suggest that endothelial cells do have a signaling machinery distinct from that of NIH3T3 cells.
A recent report described an increase of [ 3 H]thymidine incorporation in KDR/Rlk-1-overexpressing NIH3T3 cells in response to VEGF (Millauer et al., 1994) . However, the degree of DNA synthesis was not compared to that observed in the presence of other growth factors or serum.
The existence of such an endothelial cell speci®c signal transduction machinery is supported by the dierence in time course of MAP kinase activation between endothelial cells and NIH3T3-KDR cells in response to VEGF (Figure 6 ). MAP kinase was promptly activated within 5 min and downregulated within 10 min in the primary endothelial cells. This is similar to the activation in NIH3T3 upon stimulation with serum. However, NIH3T3-KDR cells showed a signi®cant delay for both activation and downregulation of MAP kinase. We suggest that this slower response of MAP kinase is mainly mediated through the PKC pathway, since NIH3T3-KDR cells treated with TPA showed signi®cantly lowered levels of MAP kinase activation in response to VEGF.
PLCg is almost equally activated both in NIH3T3-KDR cells and primary endothelial cells (Figure 8) . Therefore, it is a critical question whether or not PLCg (and PKC) pathway strongly contributes to the rapid activation of MAP kinase in endothelial cells. There seem at least two possibilities: one is that a set of PKC family members dierent from that in ®broblast NIH3T3 cells are rapidly activated in endothelial cells through activation of PLCg, and induce rapid MAP kinase activation.
Another possibility is that a signaling pathway totally independent of the activation of PLCg is rapidly activated only in sinusoidal endothelial cells, resulting in a rapid stimulation of Raf-MEK-MAP kinase pathway in these cells. At this moment we do not have clear answers for those, thus, an extensive study for cellular adaptor proteins associated with and/ or activated by VEGF receptors are essential to solve these problems.
Materials and methods

Cell cultures and growth factors
NIH3T3-KDR cells overexpressing human KDR/Flk-1 were established as described previously (Sawano et al., 1996) and maintained in Dulbecco's modi®ed Eagle's medium (DMEM; Nissui, Tokyo) supplemented with 10% calf serum (CS), 2 mM L-Glutamine, 40 mg/ml kanamycin and 200 mg/ml G418 sulfate (Geneticin; Gibco BRL, Grand Island, NY). 3Y1 cells, a rat embryonic ®broblast cell line (Kimura et al., 1995) were cultured in DMEM supplemented with 10% fetal calf serum (FCS), 2 mM L-Glutamine, 40 mg/ ml kanamycin. Sinusoidal endothelial cells were isolated from a rat liver according to the procedure previously described and grown in EGM-UV medium (Kurabo, Osaka) supplemented with VEGF (10 ng/ml) (Yamane et al., 1994) . Recombinant human VEGF (165 amino-acid form) was puri®ed by heparin column chromatography from the conditioned medium of Sf-9 insect cells expressing the VEGF gene. A portion of the puri®ed VEGF used here was kindly provided by Dr Gera Neufeld (TIT, Haifa, Israel) (Cohen et al., 1992) . Recombinant bFGF was obtained from Oncogene Science (Uniondale, NY).
Antibodies
Rabbit polyclonal antisera to KDR/Flk-1 were generated against a synthetic peptide of KDR/Flk-1 (residue 1294 to 1316) for use in immunoblotting and against a KDR/Flk-1-glutathione S-transferase (GST) fusion protein (residue 1177 to 1356) for use in immunoprecipitation. Rabbit polyclonal antiserum to Flt-1 was generated as described previously (Seetharam et al., 1995) . A monoclonal antibody speci®c to phosphotyrosine (PY-20) was obtained from ICN Biochemicals (Costa Mesa, Calif.) and mixed monoclonal antibodies to PLC-g were obtained from Upstate Biotechnology Incorporated (Lake Placid, NY). Secondary antibodies conjugated to horseradish peroxidase (HRP) were purchased from Amersham (Arlington Heights, IL).
Immunoblotting and immunoprecipitation
For in vivo phosphorylation, cells were starved overnight in serum-free medium and stimulated with 10 ng/ml VEGF for the indicated times at 378C. The cells were washed in ice-cold phosphate buered saline (PBS)-0.1 mM Na 3 VO 4 twice and lysed in 1% Triton X-100 lysis buer (50 mM N-2 hydroxyethylpiperazine-N-2-ethane sulphonic acid (HEPES), pH 7.4, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 2% aprotinin, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 50 mM NaF, 10 mM Na4P 2 O 7 and 2 mM Na 3 VO 4 ). The lysates were clari®ed by centrifugation (15 000 r.p.m.610 min). Protein concentrations were measured using Bio-Rad protein assay (Bio-Rad, Richmond, CA) and the same amounts of protein of each sample were used for analysis. For immunoblotting, the cell lysates were subjected to SDSpolyacrylamide gel electrophoresis (PAGE) and transferred onto Immobilon (Millipore, Beaford, MA). After transfer, the blots were incubated with the blocking solution (5% bovine serum albumin (BSA) in washing buer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.3% Tween 20) and probed with the primary antibody diluted in the blocking solution. The signal was visualized using HRP-conjugated secondary antibodies and enhanced chemiluminescence (ECL; Amersham) according to the manufacturer's instructions.
For immunoprecipitation, cell lysates were incubated with the primary antibody and then protein A (for anti-KDR/Flk-1 antiserum) or G (for anti-PLC-g antibodies) sepharose beads (Pharmacia) were added. The beads were washed ®ve times with 1% Triton X-100 lysis buer. For experiments involving complex formation, 0.1% Triton X-100 lysis buer was used for washing.
Binding assays and cross-linking experiments
VEGF was labeled with 125 I as described previously (Seetharam et al., 1995) . A speci®c activity of 3.1610 5 c.p.m./ng was obtained. Sinusoidal endothelial cells were starved in EGM-UV medium without VEGF for 6 ± 7 h. Cell monolayers were incubated with binding medium (DMEM, 25 mM HEPES, pH 7.5 and 0.1% BSA) containing with 125 I-VEGF (1 ng/ml) for 90 min at 48C. In some experiments an excess amount of unlabeled VEGF was added as a competitor. After incubation, the cells were washed three times with binding medium and twice with PBS-0.1% BSA, and then lysed in 0.5 N NaOH. The radioactivities were measured using a g-counter (Sawano et al., 1996) .
Receptor-bound 125 I-VEGF was cross-linked with disuccinimidyl suberate (DSS, Pierce Chemical, Rockford, IL) and solubilized in RIPA buer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate, 20 mM EDTA, 2% aprotinin and 1 mM PMSF) (Seetharam et al., 1995) . The resultant lysates were directly subjected to SDS ± PAGE. For immunoprecipitation, cell lysates were incubated with pre-immune serum, anti-Flt-1 antiserum or anti-KDR/Flk-1 antiserum overnight at 48C. In some experiments, the corresponding excess antigen was added as a competitor. The immunoprecipitates were analysed by SDS ± PAGE and autoradiography at 7708C.
Tunicamycin treatment
Cells were incubated with various concentrations of tunicamycin for 24 h (Duksin and Mahoney, 1982) and then lysed for immunoblotting with anti-KDR/Flk-1 antiserum as described above.
Cell surface receptor biotinylation
Cell surfaces were labeled with sulpho-NHS-Biotin (Pierce Chemical) according to the previous procedure (LaRochelle and Froehner, 1986 ) with some modi®cations. Brie¯y, cells were rinsed with ice-cold PBS and then incubated in PBS containing 1 mg/ml sulpho-NHS-Biotin for 30 min at 48C. The reaction was stopped by washing with a solution containing 10 mM Tris-HCl, pH 7.4 and 0.1 M Glycine. Cells were lysed and subjected to immunoprecipitation with anti-KDR/Flk-1 antiserum. The immunocomplexes were resolved by SDS ± PAGE, transferred to Immobilon and detected with streptoavidine conjugated to HRP.
Pulse-chase analysis
Cells were incubated in methionine-free medium (Gibco BRL) for 30 min before labeling for 20 min with 0.15 mCi/ml of [ 35 S]methionine (ICN Biochemicals). The cells were washed and incubated in medium containing excess unlabeled methionine for 0 ± 3 h. The cells were harvested at indicated times after labeling, lysed and immunoprecipitated with anti-KDR/Flk-1 antiserum as described above.
Assay of cell growth
NIH3T3-KDR cells were grown in 24-well collagen-coated culture plates (8.5610 3 /well) and starved overnight in serum-free DMEM supplemented with 10 mg/ml transferrin and 1 mg/ml insulin (Sigma). Cells were incubated with 50 ng/ml VEGF, 50 ng/ml BSA or 10% CS for 4 days. The number of cells was counted every 24 h. Alternatively, cells (2610 4 /well) were pulse-labeled with [ 3 H]thymidine (1 mCi/ well) for 4 h. Then they were harvested on glass ®lters and incorporated radioactivity was measured. Data represented the average of duplicate samples.
In gel kinase assay of MAP kinase
The separating gels were polymerized with 0.5 mg/ml of myelin basic protein (MBP, Sigma). For down regulation of PKC, cells were treated with 200 nM TPA (Sigma) diluted in DMSO or DMSO alone for 24 h in DMEM containing 10% CS. The cells were starved in serum-free medium containing TPA or DMSO for last 8 h. Samples containing 15 mg of protein were subjected to SDS ± PAGE. Then the gels were denatured in 6 M guanidine-HCl, renatured and assayed for kinase activity as described previously (Gotoh et al., 1990) . Autoradiography was quanti®ed by densitometory with a Fuji BAS 2000 image analyzer.
